QUIDELORTHO CORP Derivative, Gain (Loss) on Derivative, Net
QUIDELORTHO CORP (QDEL) reported Derivative, Gain (Loss) on Derivative, Net of $0 for the 12-month period ending 2023-12-31, per its 10-K/A filed 2024-08-01.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2025-02-27
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for the quarter ending 2023-12-31 was $0.00.
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for the quarter ending 2023-10-01 was $0.00, a 100.00% decline year-over-year.
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for the quarter ending 2023-07-02 was $0.00, a 100.00% decline year-over-year.
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for the quarter ending 2023-01-01 was $0.00.
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2023.
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for fiscal 2023 was $4.40M.
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for fiscal 2022 was $0.00.
- QUIDELORTHO CORP derivative, gain (loss) on derivative, net for fiscal 2021 was -$1.10M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $0.00 derived: sum of 2 quarters · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-08-01 | $0.00 10-K/A · filed 2024-08-01 |
| 2023-10-01 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | |
| 2023-07-02 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2023-01-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.40M derived: sum of 2 quarters · filed 2025-02-27 | $4.40M derived: sum of 3 quarters · filed 2025-02-27 | $4.40M 10-K · filed 2025-02-27 |
| 2022-10-02 | $3.40M 10-Q · filed 2023-11-02 | $4.40M derived: sum of 2 quarters · filed 2023-11-02 | $4.40M 10-Q · filed 2023-11-02 | |
| 2022-07-03 | $1.00M 10-Q · filed 2023-08-09 | $1.00M 10-Q · filed 2023-08-09 | ||
| 2022-01-02 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $0.00 derived: sum of 2 quarters · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-08-01 | $0.00 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | |
| 2021-07-04 | $0.00 10-Q · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | -$1.10M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |